ADRA2A antagonist 1
Product Specifications
UNSPSC Description
ADRA2A antagonist 1 (compd 4n) is a potent and selective ADRA2A antagonist with an IC50 of 18 nM. ADRA2A antagonist 1 can be used for inflammation and sepsis research[1].
Target Antigen
Adrenergic Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein;Neuronal Signaling
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/adra2a-antagonist-1.html
Solubility
10 mM in DMSO
Smiles
[H][C@]12C3=C(CCN1C[C@]4([H])CC[C@H](O)[C@H](C(O[C@H]5C[C@@H](C5)N)=O)[C@@]4([H])C2)C(C=CC=C6)=C6N3
Molecular Weight
409.52
References & Citations
[1]Chayka A, et al. Structure-Based Drug Design of ADRA2A Antagonists Derived from Yohimbine. J Med Chem. 2024 Jun 10.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-163694/ADRA2A-antagonist-1-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-163694/
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
